Dr. Britten is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
86 Jonathan Lucas St
Charleston, SC 29425Phone+1 843-792-9300Fax+1 843-792-1190- Is this information wrong?
Education & Training
- University of Toronto Faculty of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 2001 - 2026
- SC State Medical License 2012 - 2025
- TX State Medical License 1997 - 2009
- American Board of Internal Medicine Medical Oncology
- Royal College of Physicians and Surgeons of CanadaInternal Medicine
- Royal College of Physicians and Surgeons of CanadaMedical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression Start of enrollment: 2001 Aug 01
- Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction Start of enrollment: 2002 May 01
- Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery Start of enrollment: 2003 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 116 citationsA phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period.Carolyn D. Britten, Fairooz F. Kabbinavar, J. Randolph Hecht, Carlo L. Bello, Jim Z. Li
Cancer Chemotherapy and Pharmacology. 2008-03-01 - 16 citationsA phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors.Margaret von Mehren, Carolyn D. Britten, Peter C Pieslor, Wayne Saville, Artemios Vassos
Investigational New Drugs. 2014-01-24 - 38 citationsTransarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot studyCarolyn D. Britten, Antoinette S. Gomes, Zev A. Wainberg, David Elashoff, Rafael G. Amado
BMC Cancer. 2012-01-14
Professional Memberships
- Member
- Member
Hospital Affiliations
- MUSC Health University Medical CenterCharleston, South Carolina
- Roper HospitalCharleston, South Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: